Long-term Results of the Treatment of Patients With Mantle Cell Lymphoma With Cladribine (2-CDA) Alone (95-80-53) or 2-CDA and Rituximab (N0189) in the North Central Cancer Treatment Group

BACKGROUND: The objective of this study was to test cladribine (2-CDA) alone and in combination with rituximab in patients with mantle cell lymphoma (MCL). METHODS: Patients with MCL were treated on 2 sequential trials. In Trial 95-80-53, patients received 2-CDA as initial therapy or at relapse. In...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Inwards, David J., Fishkin, Paul A. S., Hillman, David W., Brown, David W., Ansell, Stephen M., Kurtin, Paul J., Fonseca, Rafael, Morton, Roscoe F., Veeder, Michael H., Witzig, Thomas E.
Формат: Artigo
Язык:Inglês
Опубликовано: 2008
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3465670/
https://ncbi.nlm.nih.gov/pubmed/18470909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23537
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы